Sanara Medtech INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Sanara MedTech Inc. has issued its 2026 Proxy Statement detailing the upcoming virtual Annual Meeting of Shareholders scheduled for June 4, 2026.
NASDAQ
Sanara MedTech Inc. will hold its 2025 Annual Meeting of Shareholders virtually on May 22, 2025, to elect directors and ratify the appointment of its independent accounting firm.
NASDAQ
Sanara MedTech withdraws a proposal to increase the board size and elect a new director after the resignation of its CEO, Zachary B. Fleming.
NASDAQ
Sanara MedTech's former CEO, Zach Fleming, has resigned, leading to the appointment of Ron Nixon as CEO and the withdrawal of a proposal for a ninth director at the upcoming annual meeting.
NASDAQ
Sanara MedTech Inc. will hold its annual shareholder meeting virtually on June 12, 2024, to vote on director elections, amendments to the Certificate of Formation, approval of a Long-Term Incentive Plan, and ratification of the company's accounting firm.
NASDAQ
Sanara MedTech Inc. will hold its annual shareholder meeting virtually on June 12, 2024, to vote on director elections, a certificate of formation amendment, a new incentive plan, and auditor ratification.